Table: Shin Nippon Biomedical - 9-MTH group results

Shin Nippon Biomedical Laboratories

02/02/2024 24:00

Feb 2 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             17.98               16.37            26.19    
                 (+9.9 pct)          (+26.5 pct)      (+4.4 pct)  
  Operating          2.54                3.78             3.47    
                 (-33.0 pct)         (+14.6 pct)      (-33.8 pct) 
  Recurring          4.88                6.88             6.39    
                 (-29.0 pct)         (+46.9 pct)      (-30.5 pct) 
  Net                3.79                4.35             3.98    
                 (-12.8 pct)         (-17.1 pct)      (-34.4 pct) 
  EPS             91.14 yen          104.52 yen        95.47 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T